NORDEN
ANNOUNCEMENT NO. 14 - 18 JANUARY 2021
On 4 November 2020, NORDEN initiated a share buy-back programme in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buy-back programme runs from 4 November 2020 up to and including no later than end February 2021. For details please see announcement no. 87 of 4 November 2020.
Under the share buy-back programme, NORDEN will purchase shares for up to a total of USD 20 million (approximately DKK 126 million). Under the programme, the following transactions have been made:
Date | Number of shares | Average purchase price (DKK) | Transaction value (DKK)
|
Total, last announcement |
599,000 |
110.58 |
66,234,638 |
11/1/2021 | 13,000 | 117.86 | 1,532,180 |
12/1/2021 | 12,000 | 120.65 | 1,447,800 |
13/1/2021 | 10,000 | 121.89 | 1,218,900 |
14/1/2021 | 10,000 | 122.02 | 1,220,200 |
15/1/2021 | 10,000 | 120.49 | 1,204,900 |
Accumulated | 654,000 | 111.40 | 72,858,618 |
Since the share buy-back programme was initiated on 4 November 2020, the total number of repurchased shares is 654,000 at a total amount of DKK 72,858,618.
With the transactions stated above, NORDEN holds a total of 3,013,467 treasury shares, corresponding to 7.40%. The total number of shares in NORDEN is 40,700,000 million. Adjusted for treasury shares, the number of shares is 37,686,533.
Kind regards,
Dampskibsselskabet NORDEN A/S
Klaus Nyborg
Chairman
For further information:
Klaus Nyborg, Chairman, tel.: +45 3315 0451
Attachments
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Robex Resources Inc.18.9.2025 08:01:56 CEST | Press release
Robex Announces Acceleration of Warrant Expiry Date
ONWARD Medical NV18.9.2025 07:30:00 CEST | Press release
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy
Sampo plc18.9.2025 07:30:00 CEST | Press release
Sampo plc’s share buybacks 17 September 2025
Biotalys NV18.9.2025 07:00:00 CEST | Press release
Biotalys Reports Half-Year 2025 Financial Results and Business Highlights
F. Hoffmann-La Roche Ltd18.9.2025 07:00:00 CEST | Press release
Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom